日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Author Correction: Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial

作者更正:Vorasidenib 和 ivosidenib 治疗 IDH1 突变型低级别胶质瘤:一项随机、围手术期 1 期试验

Mellinghoff, Ingo K; Lu, Min; Wen, Patrick Y; Taylor, Jennie W; Maher, Elizabeth A; Arrillaga-Romany, Isabel; Peters, Katherine B; Ellingson, Benjamin M; Rosenblum, Marc K; Chun, Saewon; Le, Kha; Tassinari, Ania; Choe, Sung; Toubouti, Youssef; Schoenfeld, Steven; Pandya, Shuchi S; Hassan, Islam; Steelman, Lori; Clarke, Jennifer L; Cloughesy, Timothy F

CTNI-53. A GLOBAL, RANDOMIZED, DOUBLE-BLINDED, PHASE 3 STUDY OF VORASIDENIB VERSUS PLACEBO IN PATIENTS WITH ADULT-TYPE DIFFUSE GLIOMA WITH AN IDH1/2 MUTATION (INDIGO): UPDATED EFFICACY RESULTS

CTNI-53. 一项全球性、随机、双盲、3期研究,比较沃拉西地尼与安慰剂治疗携带IDH1/2突变的成人型弥漫性胶质瘤患者的疗效(INDIGO):最新疗效结果

Dodington, David W; Serra, Stefano; Bracey, Tim; Chetty, Runjan; Nowak, Klaudia M; Mellinghoff, Ingo K; van den Bent, Martin J; Touat, Mehdi; Blumenthal, Deborah T; Peters, Katherine B; Ellingson, Benjamin M; Clarke, Jennifer L; Mendez, Joe; Yust-Katz, Shlomit; Mason, Warren P; Ducray, Francois; Umemura, Yoshie; Nabors, Burt; Hottinger, Andreas F; Arakawa, Yoshiki; Sepulveda, Juan M; Wick, Wolfgang; Soffietti, Riccardo; Perry, James R; Giglio, Pierre; de la Fuente, Macarena; Maher, Elizabeth A; Tron, Adriana E; Zhao, Dan; Pandya, Shuchi S; Steelman, Lori; Hassan, Islam; Wen, Patrick Y; Cloughesy, Timothy F

Pharmacokinetics/pharmacodynamics of ivosidenib in advanced IDH1-mutant cholangiocarcinoma: findings from the phase III ClarIDHy study

ivosidenib在晚期IDH1突变型胆管癌中的药代动力学/药效学:来自III期ClarIDHy研究的结果

Fan, Bin; Abou-Alfa, Ghassan K; Zhu, Andrew X; Pandya, Shuchi S; Jia, Hongxia; Yin, Feng; Gliser, Camelia; Hua, Zhaowei; Hossain, Mohammad; Yang, Hua

Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma

沃拉西尼治疗IDH1或IDH2突变型低级别胶质瘤

Mellinghoff, Ingo K; van den Bent, Martin J; Blumenthal, Deborah T; Touat, Mehdi; Peters, Katherine B; Clarke, Jennifer; Mendez, Joe; Yust-Katz, Shlomit; Welsh, Liam; Mason, Warren P; Ducray, François; Umemura, Yoshie; Nabors, Burt; Holdhoff, Matthias; Hottinger, Andreas F; Arakawa, Yoshiki; Sepulveda, Juan M; Wick, Wolfgang; Soffietti, Riccardo; Perry, James R; Giglio, Pierre; de la Fuente, Macarena; Maher, Elizabeth A; Schoenfeld, Steven; Zhao, Dan; Pandya, Shuchi S; Steelman, Lori; Hassan, Islam; Wen, Patrick Y; Cloughesy, Timothy F

Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial

Vorasidenib 和 ivosidenib 治疗 IDH1 突变型低级别胶质瘤:一项随机、围手术期 1 期试验

Mellinghoff, Ingo K; Lu, Min; Wen, Patrick Y; Taylor, Jennie W; Maher, Elizabeth A; Arrillaga-Romany, Isabel; Peters, Katherine B; Ellingson, Benjamin M; Rosenblum, Marc K; Chun, Saewon; Le, Kha; Tassinari, Ania; Choe, Sung; Toubouti, Youssef; Schoenfeld, Steven; Pandya, Shuchi S; Hassan, Islam; Steelman, Lori; Clarke, Jennifer L; Cloughesy, Timothy F

Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial

Ivosidenib治疗IDH1突变晚期胆管癌患者的最终总生存期疗效结果:3期随机临床试验ClarIDHy

Zhu, Andrew X; Macarulla, Teresa; Javle, Milind M; Kelley, R Kate; Lubner, Sam J; Adeva, Jorge; Cleary, James M; Catenacci, Daniel V T; Borad, Mitesh J; Bridgewater, John A; Harris, William P; Murphy, Adrian G; Oh, Do-Youn; Whisenant, Jonathan R; Lowery, Maeve A; Goyal, Lipika; Shroff, Rachna T; El-Khoueiry, Anthony B; Chamberlain, Christina X; Aguado-Fraile, Elia; Choe, Sung; Wu, Bin; Liu, Hua; Gliser, Camelia; Pandya, Shuchi S; Valle, Juan W; Abou-Alfa, Ghassan K

Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial

Vorasidenib,一种突变型IDH1/2双重抑制剂,用于治疗复发性或进展性胶质瘤;首次人体I期试验结果

Mellinghoff, Ingo K; Penas-Prado, Marta; Peters, Katherine B; Burris, Howard A 3rd; Maher, Elizabeth A; Janku, Filip; Cote, Gregory M; de la Fuente, Macarena I; Clarke, Jennifer L; Ellingson, Benjamin M; Chun, Saewon; Young, Robert J; Liu, Hua; Choe, Sung; Lu, Min; Le, Kha; Hassan, Islam; Steelman, Lori; Pandya, Shuchi S; Cloughesy, Timothy F; Wen, Patrick Y

Molecular and morphological changes induced by ivosidenib correlate with efficacy in mutant- IDH1 cholangiocarcinoma

ivosidenib 诱导的分子和形态变化与突变型 IDH1 胆管癌的疗效相关

Elia Aguado-Fraile, Ania Tassinari, Yuko Ishii, Carlie Sigel, Maeve A Lowery, Lipika Goyal, Camelia Gliser, Liewen Jiang, Shuchi S Pandya, Bin Wu, Nabeel Bardeesy, Sung Choe, Vikram Deshpande

Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma

突变型IDH1抑制剂Ivosidenib的I期研究:在晚期软骨肉瘤患者中的安全性和临床活性

Tap, William D; Villalobos, Victor M; Cote, Gregory M; Burris, Howard; Janku, Filip; Mir, Olivier; Beeram, Murali; Wagner, Andrew J; Jiang, Liewen; Wu, Bin; Choe, Sung; Yen, Katharine; Gliser, Camelia; Fan, Bin; Agresta, Sam; Pandya, Shuchi S; Trent, Jonathan C

Ivosidenib in Isocitrate Dehydrogenase 1-Mutated Advanced Glioma

伊沃西尼治疗异柠檬酸脱氢酶 1 突变型晚期胶质瘤

Mellinghoff, Ingo K; Ellingson, Benjamin M; Touat, Mehdi; Maher, Elizabeth; De La Fuente, Macarena I; Holdhoff, Matthias; Cote, Gregory M; Burris, Howard; Janku, Filip; Young, Robert J; Huang, Raymond; Jiang, Liewen; Choe, Sung; Fan, Bin; Yen, Katharine; Lu, Min; Bowden, Chris; Steelman, Lori; Pandya, Shuchi S; Cloughesy, Timothy F; Wen, Patrick Y